SCHEMBL26672964

SCHEMBL26672964

Cc1nc(C(=O)O)cnc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.46
HPGD P15428 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HSD17B10 Q99714 1/20 0.46
KDM4E B2RXH2 9/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
HCAR2 Q8TDS4 4/20 0.39
DAO P14920 1/20 0.39
NAPRT Q6XQN6 2/20 0.38
TSHR P16473 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
ACMSD Q8TDX5 1/20 0.37
AKR1B1 P15121 1/20 0.37
P4HTM Q9NXG6 2/20 0.36
P4HA1 P13674 1/20 0.36
MIF P14174 1/20 0.36
HIF1A Q16665 1/20 0.35
PKM P14618 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL702638 0.83 ALOX15 (0.48) ALOX15HPGDALDH1A1HSD17B10KDM4E
SCHEMBL30112000 0.83 ALOX15 (0.48) ALOX15HPGDALDH1A1HSD17B10KDM4E
SCHEMBL29488827 0.79 ALDH1A1 (0.46) ALOX15HPGDALDH1A1HSD17B10KDM4E
SCHEMBL4221972 0.79 ALDH1A1 (0.46) ALOX15HPGDALDH1A1HSD17B10KDM4E
SCHEMBL26673061 0.79 MAPK1 (0.44) HPGDALDH1A1HSD17B10KDM4EL3MBTL1
SCHEMBL13588543 0.78 ALDH1A1 (0.44) ALOX15HPGDALDH1A1HSD17B10KDM4E
SCHEMBL1105939 0.75 ALDH1A1 (0.46) ALOX15HPGDALDH1A1HSD17B10KDM4E
SCHEMBL10335107 0.75 ALOX15 (0.46) ALOX15HPGDALDH1A1HSD17B10KDM4E
SCHEMBL19913376 0.75 ALOX15 (0.42) ALOX15HPGDALDH1A1HSD17B10KDM4E
SCHEMBL31132876 0.75 KDM4E (0.51) ALOX15HPGDALDH1A1HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270198-A1 PYRIDONE COMPOUNDS AS TRPA1 INHIBITORS D. E. SHAW RESEARCH, LLC 2025-08-28 US disclosed
EP-4562015-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 EP disclosed
EP-4519250-A1 PYRIDONE COMPOUNDS AS TRPA1 INHIBITORS D.E. Shaw Research, LLC (US) 2025-03-12 EP disclosed
CN-119451948-A Pyridone compounds as TRPA1 inhibitors D·E·萧尔研究有限责任公司 2025-02-14 CN disclosed
WO-2024026481-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed
WO-2023215775-A1 PYRIDONE COMPOUNDS AS TRPA1 INHIBITORS D. E. SHAW RESEARCH, LLC (US) 2023-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270198-A1 PYRIDONE COMPOUNDS AS TRPA1 INHIBITORS TRPA1, TRPV1, TRPV6 ALOX15 111/4885HPGD 211/4885ALDH1A1 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.